Hologic

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics. 

The filing didn’t specify where or when the layoffs would take place, except they are part of a restructuring of its diagnostics division, which has been losing money due to a drop in sale of COVID tests.

The situation in Central Massachusetts, where 15.6% of named executive officers are female, largely mirrors the Massachusetts rate of 16.1% determined in a statewide census.

Marlborough women’s health firm Hologic has partnered with nonprofit Know Your Lemons for breast cancer awareness month as part of its initiative to increase early detection of breast cancer.

Marlborough-based Hologic, a medical technology firm specializing in women’s health, has entered into a partnership with international pharmaceutical firm Bayer to provide enhanced imaging mammogram services. 

Hologic reported a 74.6% revenue decrease for its COVID-19 related diagnostics testing in its third quarter as compared to last year, indicating a significant drop-off in demand for COVID testing.

Marlborough medical device manufacturer Hologic has received U.S. Food and Drug Administration clearance for a new combined test that can detect influenza A and B, respiratory syncytial virus (RSV) and coronavirus.

Marlborough medical technology company Hologic Inc. reported a 28.5% decrease in revenue in the second quarter, as compared to the same time period last year.

Milford life sciences equipment manufacturer Waters Corp. is among the top 10 companies in the state for gender diversity in executive leadership.

Marlborough medical technology company Hologic Inc., reported a decrease in profits of 62.5%, to $187 million, in the first quarter of 2023, which in the same period of the previous year was $499 million.